Coherence Neuro co-founder Ben Woodington describes an investigational implant intended to record electrical activity and stimulate tissue around brain tumors. He explains the company’s proposed approach and the role of data analysis in its research.
Woodington discusses a clinical studyExperimental validation tests a prediction or proposed mechanism with measured observations from a suitable real-world or laboratory experiment. in Australia, future long-term studies and potential other applications. His discussion describes experimental work and company expectations; effectiveness and safety for cancer treatment are not established by the interview.
Watch on YouTube
